Oncology Institute (TOIIW) Cash from Investing Activities (2020 - 2026)

Oncology Institute (TOIIW) has 7 years of Cash from Investing Activities data on file, last reported at -$1.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 415.84% year-over-year to -$1.0 million; the trailing twelve-month figure through Mar 2026 stood at -$3.9 million (down 114.7% YoY), and the FY2025 full-year result was -$3.1 million, down 106.65% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$1.0 million, up from -$1.1 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $24.9 million in Q2 2023 and bottomed at -$87.8 million in Q3 2022.
• The 5-year median for Cash from Investing Activities is -$604000.0 (2025), against an average of -$1.6 million.
• The widest annual swing landed in 2022, when Cash from Investing Activities sank 9139.89%; it then jumped 1936.43% in 2023.
• A 5-year view of Cash from Investing Activities shows it stood at -$32.6 million in 2022, then surged by 135.7% to $11.6 million in 2023, then slumped by 115.09% to -$1.8 million in 2024, then soared by 39.6% to -$1.1 million in 2025, then increased by 1.7% to -$1.0 million in 2026.
• The last three Cash from Investing Activities figures came in at -$1.0 million (Q1 2026), -$1.1 million (Q4 2025), and -$604000.0 (Q3 2025), per Business Quant data.

Peer Comparison